Identification of high-risk SNPs in SLC22A transporter genes: their potential role in PCOS and metformin uptake
Abstract
Polycystic ovary syndrome is a prevalent, heterogeneous endocrine and metabolic disorder affecting approximately 10% of women of reproductive age, often characterized by hyperandrogenism, anovulation, and insulin resistance. Metformin, a first-line treatment for type 2 diabetes, is also widely prescribed for PCOS to reduce insulin resistance and induce ovulation. However, therapeutic response varies significantly across individuals, partly due to genetic variations in solute carrier (SLC) transporters. The organic cation transporter family, encoded by SLC22A1 (O15245), SLC22A2 (O15244), and SLC22A3 (O75751), facilitates metformin uptake into hepatocytes and renal excretion. Using an in silico pipeline, Align GVGD, PolyPhen-2, PROVEAN, PANTHER, PhD-SNP, and the ensemble predictor Meta-SNP, we screened 14 deleterious nonsynonymous SNPs. Solvent accessibility values were derived using NetSurfP, indicating that L42R (RSA: 0.54, ASA: 96.2 Å2) and F422S (RSA: 0.49, ASA: 85.7 Å2) are surface-exposed and likely to influence protein interaction. In contrast, R175L (RSA: 0.07, ASA: 18.4 Å2) and T275M (RSA: 0.06, ASA: 21.1 Å2) were buried and may impact local folding. ΔΔG predictions using MuPro ranged from -0.01745 to -1.99395, consistently indicating decreased protein stability. Structural models were built in SWISS-MODEL and validated via MolProbity scores (85%), and PROSA Z-scores (-6.8 to -8.2). Functional enrichment of the PPI network (STRING-DB) highlighted significant roles in…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.